<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">cyto</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4231567</article-id><article-id pub-id-type="pmcid-ver">PMC4231567.1</article-id><article-id pub-id-type="pmcaid">4231567</article-id><article-id pub-id-type="pmcaiid">4231567</article-id><article-id pub-id-type="pmid">24866990</article-id><article-id pub-id-type="doi">10.1002/cyto.a.22478</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>OMIP-022: Comprehensive assessment of antigen-specific human T-cell functionality and memory</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Graves</surname><given-names initials="AJ">Andrew J</given-names></name><xref ref-type="aff" rid="au1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Padilla</surname><given-names initials="MG">Marcelino G</given-names></name><xref ref-type="aff" rid="au1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hokey</surname><given-names initials="DA">David A</given-names></name><xref ref-type="aff" rid="au1"/></contrib><aff id="au1"><institution>Aeras, Rockville</institution><addr-line>Maryland USA</addr-line></aff></contrib-group><author-notes><corresp id="cor1">*Correspondence to: Andrew J. Graves. E-mail: <email>agraves@aeras.org</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>27</day><month>5</month><year>2014</year></pub-date><volume>85</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">245220</issue-id><fpage>576</fpage><lpage>579</lpage><history><date date-type="received"><day>05</day><month>12</month><year>2013</year></date><date date-type="rev-recd"><day>12</day><month>2</month><year>2014</year></date><date date-type="accepted"><day>10</day><month>4</month><year>2014</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>11</month><year>2014</year></date></event><event event-type="pmc-live"><date><day>15</day><month>12</month><year>2014</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2015-01-15 02:05:29.667"><day>15</day><month>01</month><year>2015</year></date></event></pub-history><permissions><copyright-statement>&#169; 2014 The Authors. Published by Wiley Periodicals, Inc.</copyright-statement><copyright-year>2014</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cyto0085-0576.pdf"/><kwd-group><kwd>OMIP</kwd><kwd>cytometry</kwd><kwd>FACS</kwd><kwd>tuberculosis</kwd><kwd>T cell</kwd><kwd>ICS</kwd><kwd>cytokine staining</kwd><kwd>T-cell memory</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>P<sc>urpose</sc>
<sc>and</sc> A<sc>ppropriate</sc> S<sc>ample</sc> T<sc>ypes</sc></title><p>This flow cytometry antibody panel was developed and optimized for the characterization of CD4+ and CD8+ T-cell memory and functional responses in adult and infant cryopreserved peripheral blood mononuclear cells (PBMC) stimulated with peptide pools to various antigens of interest (Table<xref ref-type="table" rid="tbl1">1</xref>). The panel has been used to evaluate <italic toggle="yes">Mycobacterium tuberculosis</italic> (TB) antigen-specific responses in clinical trial specimens, and is currently undergoing assay qualification.</p><table-wrap id="tbl1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Summary table for application of OMIP-022</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Purpose</th><th align="center" rowspan="1" colspan="1">T-cell phenotyping, memory categorization, cytokine production, and function following in vitro stimulation</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Species</td><td align="left" rowspan="1" colspan="1">Human</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell types</td><td align="left" rowspan="1" colspan="1">Cryopreserved PBMC (adult and infant)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cross references</td><td align="left" rowspan="1" colspan="1">OMIP-001, OMIP-008, OMIP-009, and OMIP-014</td></tr></tbody></table></table-wrap></sec><sec><title>B<sc>ackground</sc></title><p>The lack of a correlate of immunity is a source of frustration in TB research <xref rid="b1" ref-type="bibr">1</xref>. As such, it is crucial for TB vaccine researchers to &#8220;cast a wide net&#8221; when assessing immune responses to clinical trial candidates while minimizing the amount of specimen required to generate these data. This panel (Table<xref ref-type="table" rid="tbl2">2</xref>) began as an incremental enhancement to OMIP-014 <xref rid="b2" ref-type="bibr">2</xref>, and included markers for dump (fixable viability dye, CD14, and CD19), T-cell phenotype (CD3, CD4, and CD8), Th1 cytokines (IFN-&#947; and TNF), a Th2 cytokine (IL-4), T-cell proliferation cytokine (IL-2), degranulation (CD107a), and activation (CD154). We have also expanded the panel to include memory markers (CCR7 and CD45RO), a Th17 cytokine (IL-17A), and an IL-10 superfamily cytokine (IL-22, used in place of IL-4).</p><table-wrap id="tbl2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Reagents used for OMIP-022</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Specificity</th><th align="center" rowspan="1" colspan="1">Clone</th><th align="center" rowspan="1" colspan="1">Fluorochrome</th><th align="center" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Viability Dye</td><td align="left" rowspan="1" colspan="1">&#8211;</td><td align="left" rowspan="1" colspan="1">AViD</td><td align="left" rowspan="1" colspan="1">Dump</td></tr><tr><td align="left" rowspan="1" colspan="1">CD14</td><td align="left" rowspan="1" colspan="1">M5E2</td><td align="left" rowspan="1" colspan="1">V500</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CD19</td><td align="left" rowspan="1" colspan="1">HIB19</td><td align="left" rowspan="1" colspan="1">V500</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CD3</td><td align="left" rowspan="1" colspan="1">UCHT1</td><td align="left" rowspan="1" colspan="1">ECD</td><td align="left" rowspan="1" colspan="1">Phenotype</td></tr><tr><td align="left" rowspan="1" colspan="1">CD4</td><td align="left" rowspan="1" colspan="1">RPA-T4</td><td align="left" rowspan="1" colspan="1">APC-eFluor 780</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CD8</td><td align="left" rowspan="1" colspan="1">HIT8a</td><td align="left" rowspan="1" colspan="1">Ax700</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CCR7</td><td align="left" rowspan="1" colspan="1">G043H7</td><td align="left" rowspan="1" colspan="1">BV605</td><td align="left" rowspan="1" colspan="1">Memory</td></tr><tr><td align="left" rowspan="1" colspan="1">CD45RO</td><td align="left" rowspan="1" colspan="1">UCHL1</td><td align="left" rowspan="1" colspan="1">BV785</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IFN-&#947;</td><td align="left" rowspan="1" colspan="1">B27</td><td align="left" rowspan="1" colspan="1">V450</td><td align="left" rowspan="1" colspan="1">Th1</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-2</td><td align="left" rowspan="1" colspan="1">MQ1&#8211;17H12</td><td align="left" rowspan="1" colspan="1">PE</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TNF</td><td align="left" rowspan="1" colspan="1">MAb11</td><td align="left" rowspan="1" colspan="1">PE-Cy7</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IL-17A</td><td align="left" rowspan="1" colspan="1">BL168</td><td align="left" rowspan="1" colspan="1">PerCP-Cy5.5</td><td align="left" rowspan="1" colspan="1">Th17</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-22</td><td align="left" rowspan="1" colspan="1">IL22JOP</td><td align="left" rowspan="1" colspan="1">APC</td><td align="left" rowspan="1" colspan="1">Th22</td></tr><tr><td align="left" rowspan="1" colspan="1">CD107a</td><td align="left" rowspan="1" colspan="1">H4A3</td><td align="left" rowspan="1" colspan="1">Ax488</td><td align="left" rowspan="1" colspan="1">Degranulation</td></tr><tr><td align="left" rowspan="1" colspan="1">CD154</td><td align="left" rowspan="1" colspan="1">TRAP1</td><td align="left" rowspan="1" colspan="1">PE-Cy5</td><td align="left" rowspan="1" colspan="1">Activation/B-Cell Help</td></tr></tbody></table></table-wrap><p>We chose to combine viability dye and dump markers on the same channel using AViD and V500 (for CD14 and CD19), thus freeing additional channels on the violet laser. For phenotyping, CD3 remains on ECD and CD4 on APC-eFluor 780.</p><p>Th1 cytokines have been shown to be critical for controlling TB <xref rid="b3" ref-type="bibr">3</xref>&#8211;<xref rid="b9" ref-type="bibr">9</xref>. To assess Th1 responses, we utilize antibodies against tumor necrosis factor (TNF) and IFN-&#947;. In designing this panel, we moved TNF to PE-Cy7 to improve detection of this cytokine, as fluorescein isothiocyanate (FITC) is comparatively dimmer and more prone to photobleaching. The recently introduced Brilliant Violet series of fluorochromes represents a bright and economical set of tools for detecting markers via the violet laser. Brilliant Violet 421 (BV421) was previously shown to be of similar brightness to PE <xref rid="b10" ref-type="bibr">10</xref>, and was initially chosen as a replacement fluorochrome for IFN-&#947;. However, further investigation showed that any increase in antigen-specific response detected using the BV421 conjugate was matched with a significant increase in IFN-&#947; background. This increased background was observed using both the B27 (BD Biosciences, San Jose, CA) and the 4S.B3 (Biolegend, San Diego, CA) clones. When this background population was excluded from the IFN-&#947; gate of the BV421 conjugates, the responses detected using either the BV421 conjugates or the V450 conjugate were similar. This issue, combined with the increased cost of the reagent, led us to choose to continue to use the V450 conjugate for IFN-&#947; detection in this panel.</p><p>Interleukin-2 (IL-2) is a cytokine responsible for T-cell proliferation and differentiation <xref rid="b11" ref-type="bibr">11</xref>,<xref rid="b12" ref-type="bibr">12</xref> that also may play a role in TB immunity <xref rid="b13" ref-type="bibr">13</xref>. In our panel, we use PE for bright and efficient detection of this cytokine.</p><p>As <italic toggle="yes">M. tuberculosis</italic> is a facultative intracellular bacteria, cytolytic activity may be necessary to help control the disease. CD107a (LAMP-1) is a marker for degranulation and an indirect marker for cytolytic function <xref rid="b14" ref-type="bibr">14</xref>,<xref rid="b15" ref-type="bibr">15</xref>. Ideally, lytic proteins such as Perforin would be costained with the CD107a to confirm the cytotoxic potential of the CD107a+ cells. To this point, we are examining future iterations of this panel that may include a lytic marker. However, the current constraints of this panel limit our ability to add an additional marker without harming sensitivity in detecting the other markers of interest. To accommodate the change in fluorochrome for the detection of TNF, we moved CD107a to FITC initially, and then replaced FITC with the enhanced stability of Alexa Fluor 488 (Ax488).</p><p>The Brilliant Violet series of fluorochromes has also allowed us to include the memory markers CCR7 and CD45RO. CCR7 is responsible for homing T-cells to lymph nodes <xref rid="b16" ref-type="bibr">16</xref> and is expressed on na&#239;ve and central memory T-cells (T<sub>CM</sub>) <xref rid="b17" ref-type="bibr">17</xref>. CD45RO is the smallest isoform of CD45, and has been shown to be expressed on effector memory (T<sub>EM</sub>) and T<sub>CM</sub>
<xref rid="b18" ref-type="bibr">18</xref>. The inclusion of both markers allows for T-cells to be categorized as na&#239;ve, T<sub>CM</sub>, T<sub>EM</sub>, or effector T-cells. We chose Brilliant Violet 605 for CCR7 as it was the next brightest available Brilliant Violet dye and CCR7 is expressed as a continuum (not distinct populations) <xref rid="b19" ref-type="bibr">19</xref>. The binding kinetics of the CCR7 antibody has shown optimal staining when incubated at 37&#176;C (see staining protocol in Supporting Information). Brilliant Violet 785 was chosen for CD45RO based on antibody availability and minimal spectral overlap to other markers.</p><p>IL-17A is secreted by Th17 T helper cells and acts to recruit innate immune effector cells to the site of inflammation <xref rid="b20" ref-type="bibr">20</xref>. Recent works <xref rid="b21" ref-type="bibr">21</xref>,<xref rid="b22" ref-type="bibr">22</xref> have suggested a strong role for IL-17A in tuberculosis immunity. As such, we initially replaced the MIP-1&#946; from OMIP-014 with and anti-IL-17A antibody. In our hands, the PerCP-Cy5.5 on CD8 causes high spectral overlap into the Ax700 channel used for IL-17A. As IL-17A is lowly expressed compared to CD8 (and as PerCP-Cy5.5 is fluorescently brighter), we exchanged the fluorochromes for these two markers to minimize the impact of the high compensation.</p><p>As an effect of changing CD8 to Ax700, a reduction in CD8+ events [perhaps an escapee phenomenon <xref rid="b23" ref-type="bibr">23</xref>] was noted using Ax700 to detect CD8, but was mitigated by staining for CD8 intracellularly.</p><p>IL-4, previously included with OMIP-014, is a representative Th2 cytokine. This interleukin is extremely difficult to detect and, in our hands, is inconsistent. We continue to include this marker as an option when assessing clinical trial specimens in which Th2 is considered a desired response. Recently, however, we have substituted IL-22 on APC instead of IL-4. IL-22 is part of the IL-10 superfamily <xref rid="b24" ref-type="bibr">24</xref>, and when coexpressed with IL-17 enhances production antimicrobial peptides in the mucosa <xref rid="b25" ref-type="bibr">25</xref>. Although poorly characterized to this point, recent research indicates that IL-22 plays a role in TB infection <xref rid="b21" ref-type="bibr">21</xref>,<xref rid="b26" ref-type="bibr">26</xref>.</p><p>CD154 was maintained on this panel as emerging evidence indicates its role as a specific and sensitive marker in detecting CD4 response <xref rid="b27" ref-type="bibr">27</xref>, as well as its roles in upregulating antimicrobial peptides <xref rid="b28" ref-type="bibr">28</xref> and its necessity for T-cell activation of B cells <xref rid="b29" ref-type="bibr">29</xref>. As indicated in OMIP-014, the inclusion of Brefeldin A in our stimulation protocol requires intracellular staining of CD154. <xref ref-type="fig" rid="fig01">Figure 1</xref> shows an example staining and analysis for adult PBMC stimulated with <italic toggle="yes">Staphylococcal enterotoxin B</italic> (<xref ref-type="fig" rid="fig01">Fig. 1</xref>A) or CMV pp65 (<xref ref-type="fig" rid="fig01">Fig. 1</xref>B).</p><fig id="fig01" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Example staining of adult human PBMC following stimulation. (A) The first two rows demonstrate the gating hierarchy from total sample to CD4/CD8 identification. A time gate is used to exclude pressure aberrations from the cytometer that may have occurred during sample acquisition. Aggregate gates are used to exclude brightly positive events that may result from antibody or cell aggregation. The bottom row demonstrates gating for cytokines and functions from CD4+ (top half) and CD8+ (bottom half) events resulting from stimulation with <italic toggle="yes">Staphylococcal enterotoxin B</italic>. Note that IL-17A and CD154 were gated on the same plot to avoid mischaracterization resulting from the increased spectral overlap observed from their fluorochromes. (B) Example plots showing memory profile of CCR7 versus CD45RO in CD4+ and CD8+ populations. Using CMV pp65 peptide pool-stimulated PBMC from a CMV-reactive donor, IFN-&#947;+ events (blue) were overlaid onto these plots (gray), confirming localization of these events to the effector memory and effector compartments.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="cyto0085-0576-f1.jpg"/></fig></sec><sec><title>S<sc>imilarity</sc>
<sc>to</sc> P<sc>ublished</sc> OMIP<sc>s</sc></title><p>As this panel assesses antigen-specific T-cell responses, it is similar to OMIP-001 <xref rid="b30" ref-type="bibr">30</xref>, OMIP-008 <xref rid="b31" ref-type="bibr">31</xref>, OMIP-009 <xref rid="b32" ref-type="bibr">32</xref>, and OMIP-014 <xref rid="b2" ref-type="bibr">2</xref>. Furthermore, this panel evolved from an initial desire to implement OMIP-014. Unlike these panels, however, our panel includes T-cell memory markers as well as an extensive combination of cytokines and functions associated with tuberculosis vaccine research. Our panel was developed for use in multicenter studies under good clinical laboratory practices conditions, and is currently undergoing assay qualification.</p></sec></body><back><ack><p>The authors thank Mario Roederer, Stephen P. Perfetto, Stephen C. De Rosa, and Michael R. Betts for their expertise and suggestions during the development and optimization of this panel. The authors declare no conflict of interest.</p></ack><ref-list><title>L<sc>iterature</sc> C<sc>ited</sc></title><ref id="b1"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hokey</surname><given-names>DA</given-names></name><name name-style="western"><surname>Ginsberg</surname><given-names>A</given-names></name></person-group><article-title>The current state of tuberculosis vaccines</article-title><source>Hum Vaccin Immunother</source><year>2013</year><volume>9</volume><fpage>2142</fpage><lpage>2146</lpage><pub-id pub-id-type="pmid">23792698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/hv.25427</pub-id><pub-id pub-id-type="pmcid">PMC3906398</pub-id></element-citation></ref><ref id="b2"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></name><name name-style="western"><surname>Carter</surname><given-names>DK</given-names></name><name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></name></person-group><article-title>OMIP-014: Validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining</article-title><source>Cytometry Part A</source><year>2012</year><volume>81A</volume><fpage>1019</fpage><lpage>1021</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22218</pub-id><pub-id pub-id-type="pmcid">PMC3581864</pub-id><pub-id pub-id-type="pmid">23081852</pub-id></element-citation></ref><ref id="b3"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruns</surname><given-names>H</given-names></name><name name-style="western"><surname>Meinken</surname><given-names>C</given-names></name><name name-style="western"><surname>Schauenberg</surname><given-names>P</given-names></name><name name-style="western"><surname>Harter</surname><given-names>G</given-names></name><name name-style="western"><surname>Kern</surname><given-names>P</given-names></name><name name-style="western"><surname>Modlin</surname><given-names>RL</given-names></name><name name-style="western"><surname>Antoni</surname><given-names>C</given-names></name><name name-style="western"><surname>Stenger</surname><given-names>S</given-names></name></person-group><article-title>Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against <italic toggle="yes">Mycobacterium tuberculosis</italic> in humans</article-title><source>J Clin Invest</source><year>2009</year><volume>119</volume><fpage>1167</fpage><lpage>1177</lpage><pub-id pub-id-type="pmid">19381021</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI38482</pub-id><pub-id pub-id-type="pmcid">PMC2673881</pub-id></element-citation></ref><ref id="b4"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunez Martinez</surname><given-names>O</given-names></name><name name-style="western"><surname>Ripoll Noiseux</surname><given-names>C</given-names></name><name name-style="western"><surname>Carneros Martin</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gonzalez Lara</surname><given-names>V</given-names></name><name name-style="western"><surname>Gregorio Maranon</surname><given-names>HG</given-names></name></person-group><article-title>Reactivation tuberculosis in a patient with anti-TNF-alpha treatment</article-title><source>Am J Gastroenterol</source><year>2001</year><volume>96</volume><fpage>1665</fpage><lpage>1666</lpage><pub-id pub-id-type="pmid">11374737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1572-0241.2001.03836.x</pub-id></element-citation></ref><ref id="b5"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keane</surname><given-names>J</given-names></name><name name-style="western"><surname>Gershon</surname><given-names>S</given-names></name><name name-style="western"><surname>Wise</surname><given-names>RP</given-names></name><name name-style="western"><surname>Mirabile-Levens</surname><given-names>E</given-names></name><name name-style="western"><surname>Kasznica</surname><given-names>J</given-names></name><name name-style="western"><surname>Schwieterman</surname><given-names>WD</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>JN</given-names></name><name name-style="western"><surname>Braun</surname><given-names>MM</given-names></name></person-group><article-title>Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent</article-title><source>N Engl J Med</source><year>2001</year><volume>345</volume><fpage>1098</fpage><lpage>1104</lpage><pub-id pub-id-type="pmid">11596589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa011110</pub-id></element-citation></ref><ref id="b6"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lammas</surname><given-names>DA</given-names></name><name name-style="western"><surname>Casanova</surname><given-names>JL</given-names></name><name name-style="western"><surname>Kumararatne</surname><given-names>DS</given-names></name></person-group><article-title>Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway</article-title><source>Clin Exp Immunol</source><year>2000</year><volume>121</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">10971505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2249.2000.01284.x</pub-id><pub-id pub-id-type="pmcid">PMC1905729</pub-id></element-citation></ref><ref id="b7"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jouanguy</surname><given-names>E</given-names></name><name name-style="western"><surname>Doffinger</surname><given-names>R</given-names></name><name name-style="western"><surname>Dupuis</surname><given-names>S</given-names></name><name name-style="western"><surname>Pallier</surname><given-names>A</given-names></name><name name-style="western"><surname>Altare</surname><given-names>F</given-names></name><name name-style="western"><surname>Casanova</surname><given-names>JL</given-names></name></person-group><article-title>IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men</article-title><source>Curr Opin Immunol</source><year>1999</year><volume>11</volume><fpage>346</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">10375558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0952-7915(99)80055-7</pub-id></element-citation></ref><ref id="b8"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Jong</surname><given-names>R</given-names></name><name name-style="western"><surname>Altare</surname><given-names>F</given-names></name><name name-style="western"><surname>Haagen</surname><given-names>IA</given-names></name><name name-style="western"><surname>Elferink</surname><given-names>DG</given-names></name><name name-style="western"><surname>Boer</surname><given-names>T</given-names></name><name name-style="western"><surname>van Breda Vriesman</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Kabel</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Draaisma</surname><given-names>JM</given-names></name><name name-style="western"><surname>van Dissel</surname><given-names>JT</given-names></name><name name-style="western"><surname>Kroon</surname><given-names>FP</given-names></name><etal/></person-group><article-title>Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients</article-title><source>Science</source><year>1998</year><volume>280</volume><fpage>1435</fpage><lpage>1438</lpage><pub-id pub-id-type="pmid">9603733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.280.5368.1435</pub-id></element-citation></ref><ref id="b9"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altare</surname><given-names>F</given-names></name><name name-style="western"><surname>Durandy</surname><given-names>A</given-names></name><name name-style="western"><surname>Lammas</surname><given-names>D</given-names></name><name name-style="western"><surname>Emile</surname><given-names>JF</given-names></name><name name-style="western"><surname>Lamhamedi</surname><given-names>S</given-names></name><name name-style="western"><surname>Le Deist</surname><given-names>F</given-names></name><name name-style="western"><surname>Drysdale</surname><given-names>P</given-names></name><name name-style="western"><surname>Jouanguy</surname><given-names>E</given-names></name><name name-style="western"><surname>Doffinger</surname><given-names>R</given-names></name><name name-style="western"><surname>Bernaudin</surname><given-names>F</given-names></name><etal/></person-group><article-title>Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency</article-title><source>Science</source><year>1998</year><volume>280</volume><fpage>1432</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">9603732</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.280.5368.1432</pub-id></element-citation></ref><ref id="b10"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chattopadhyay</surname><given-names>PK</given-names></name><name name-style="western"><surname>Gaylord</surname><given-names>B</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>A</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>N</given-names></name><name name-style="western"><surname>Raven</surname><given-names>MA</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>G</given-names></name><name name-style="western"><surname>Reuter</surname><given-names>MA</given-names></name><name name-style="western"><surname>Nur-ur Rahman</surname><given-names>AK</given-names></name><name name-style="western"><surname>Price</surname><given-names>DA</given-names></name><name name-style="western"><surname>Betts</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Brilliant violet fluorophores: A new class of ultrabright fluorescent compounds for immunofluorescence experiments</article-title><source>Cytometry Part A</source><year>2012</year><volume>81A</volume><fpage>456</fpage><lpage>466</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22043</pub-id><pub-id pub-id-type="pmid">22489009</pub-id></element-citation></ref><ref id="b11"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>KA</given-names></name></person-group><article-title>Interleukin-2: Inception, impact, and implications</article-title><source>Science</source><year>1988</year><volume>240</volume><fpage>1169</fpage><lpage>1176</lpage><pub-id pub-id-type="pmid">3131876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.3131876</pub-id></element-citation></ref><ref id="b12"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantrell</surname><given-names>DA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>KA</given-names></name></person-group><article-title>The interleukin-2 T-cell system: A new cell growth model</article-title><source>Science</source><year>1984</year><volume>224</volume><fpage>1312</fpage><lpage>1316</lpage><pub-id pub-id-type="pmid">6427923</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.6427923</pub-id></element-citation></ref><ref id="b13"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toossi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kleinhenz</surname><given-names>ME</given-names></name><name name-style="western"><surname>Ellner</surname><given-names>JJ</given-names></name></person-group><article-title>Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis</article-title><source>J Exp Med</source><year>1986</year><volume>163</volume><fpage>1162</fpage><lpage>1172</lpage><pub-id pub-id-type="pmid">2939169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.163.5.1162</pub-id><pub-id pub-id-type="pmcid">PMC2188106</pub-id></element-citation></ref><ref id="b14"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>JW</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>TL</given-names></name><name name-style="western"><surname>Willingham</surname><given-names>MC</given-names></name><name name-style="western"><surname>Pastan</surname><given-names>I</given-names></name><name name-style="western"><surname>August</surname><given-names>JT</given-names></name></person-group><article-title>Identification of two lysosomal membrane glycoproteins</article-title><source>J Cell Biol</source><year>1985</year><volume>101</volume><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">2409098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.101.1.85</pub-id><pub-id pub-id-type="pmcid">PMC2113627</pub-id></element-citation></ref><ref id="b15"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Betts</surname><given-names>MR</given-names></name><name name-style="western"><surname>Brenchley</surname><given-names>JM</given-names></name><name name-style="western"><surname>Price</surname><given-names>DA</given-names></name><name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></name><name name-style="western"><surname>Douek</surname><given-names>DC</given-names></name><name name-style="western"><surname>Roederer</surname><given-names>M</given-names></name><name name-style="western"><surname>Koup</surname><given-names>RA</given-names></name></person-group><article-title>Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation</article-title><source>J Immunol Methods</source><year>2003</year><volume>281</volume><fpage>65</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">14580882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-1759(03)00265-5</pub-id></element-citation></ref><ref id="b16"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebert</surname><given-names>LM</given-names></name><name name-style="western"><surname>Schaerli</surname><given-names>P</given-names></name><name name-style="western"><surname>Moser</surname><given-names>B</given-names></name></person-group><article-title>Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues</article-title><source>Mol Immunol</source><year>2005</year><volume>42</volume><fpage>799</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">15829268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molimm.2004.06.040</pub-id></element-citation></ref><ref id="b17"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name><name name-style="western"><surname>Lenig</surname><given-names>D</given-names></name><name name-style="western"><surname>Forster</surname><given-names>R</given-names></name><name name-style="western"><surname>Lipp</surname><given-names>M</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group><article-title>Two subsets of memory T lymphocytes with distinct homing potentials and effector functions</article-title><source>Nature</source><year>1999</year><volume>401</volume><fpage>708</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">10537110</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/44385</pub-id></element-citation></ref><ref id="b18"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merkenschlager</surname><given-names>M</given-names></name><name name-style="western"><surname>Beverley</surname><given-names>PC</given-names></name></person-group><article-title>Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: Human CD8 memory CTLp selectively express CD45RO (UCHL1)</article-title><source>Int Immunol</source><year>1989</year><volume>1</volume><fpage>450</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">2562244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/intimm/1.4.450</pub-id></element-citation></ref><ref id="b19"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLaughlin</surname><given-names>BE</given-names></name><name name-style="western"><surname>Baumgarth</surname><given-names>N</given-names></name><name name-style="western"><surname>Bigos</surname><given-names>M</given-names></name><name name-style="western"><surname>Roederer</surname><given-names>M</given-names></name><name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></name><name name-style="western"><surname>Altman</surname><given-names>JD</given-names></name><name name-style="western"><surname>Nixon</surname><given-names>DF</given-names></name><name name-style="western"><surname>Ottinger</surname><given-names>J</given-names></name><name name-style="western"><surname>Oxford</surname><given-names>C</given-names></name><name name-style="western"><surname>Evans</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach</article-title><source>Cytometry Part A</source><year>2008</year><volume>73A</volume><fpage>400</fpage><lpage>410</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.20555</pub-id><pub-id pub-id-type="pmcid">PMC9191630</pub-id><pub-id pub-id-type="pmid">18383316</pub-id></element-citation></ref><ref id="b20"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weaver</surname><given-names>CT</given-names></name><name name-style="western"><surname>Hatton</surname><given-names>RD</given-names></name><name name-style="western"><surname>Mangan</surname><given-names>PR</given-names></name><name name-style="western"><surname>Harrington</surname><given-names>LE</given-names></name></person-group><article-title>IL-17 family cytokines and the expanding diversity of effector T cell lineages</article-title><source>Annu Rev Immunol</source><year>2007</year><volume>25</volume><fpage>821</fpage><lpage>852</lpage><pub-id pub-id-type="pmid">17201677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.immunol.25.022106.141557</pub-id></element-citation></ref><ref id="b21"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scriba</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Kalsdorf</surname><given-names>B</given-names></name><name name-style="western"><surname>Abrahams</surname><given-names>DA</given-names></name><name name-style="western"><surname>Isaacs</surname><given-names>F</given-names></name><name name-style="western"><surname>Hofmeister</surname><given-names>J</given-names></name><name name-style="western"><surname>Black</surname><given-names>G</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>HY</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Walzl</surname><given-names>G</given-names></name><name name-style="western"><surname>Gelderbloem</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>1962</fpage><lpage>1970</lpage><pub-id pub-id-type="pmid">18209095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.180.3.1962</pub-id><pub-id pub-id-type="pmcid">PMC2219462</pub-id></element-citation></ref><ref id="b22"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khader</surname><given-names>SA</given-names></name><name name-style="western"><surname>Bell</surname><given-names>GK</given-names></name><name name-style="western"><surname>Pearl</surname><given-names>JE</given-names></name><name name-style="western"><surname>Fountain</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name name-style="western"><surname>Cilley</surname><given-names>GE</given-names></name><name name-style="western"><surname>Shen</surname><given-names>F</given-names></name><name name-style="western"><surname>Eaton</surname><given-names>SM</given-names></name><name name-style="western"><surname>Gaffen</surname><given-names>SL</given-names></name><name name-style="western"><surname>Swain</surname><given-names>SL</given-names></name><etal/></person-group><article-title>IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge</article-title><source>Nat Immunol</source><year>2007</year><volume>8</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">17351619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni1449</pub-id></element-citation></ref><ref id="b23"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gratama</surname><given-names>JW</given-names></name><name name-style="western"><surname>van der Linden</surname><given-names>R</given-names></name><name name-style="western"><surname>van der Holt</surname><given-names>B</given-names></name><name name-style="western"><surname>Bolhuis</surname><given-names>RL</given-names></name><name name-style="western"><surname>van de Winkel</surname><given-names>JG</given-names></name></person-group><article-title>Analysis of factors contributing to the formation of mononuclear cell aggregates (&#8220;escapees&#8221;) in flow cytometric immunophenotyping</article-title><source>Cytometry</source><year>1997</year><volume>29</volume><fpage>250</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">9389442</pub-id></element-citation></ref><ref id="b24"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fickenscher</surname><given-names>H</given-names></name><name name-style="western"><surname>Hor</surname><given-names>S</given-names></name><name name-style="western"><surname>Kupers</surname><given-names>H</given-names></name><name name-style="western"><surname>Knappe</surname><given-names>A</given-names></name><name name-style="western"><surname>Wittmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Sticht</surname><given-names>H</given-names></name></person-group><article-title>The interleukin-10 family of cytokines</article-title><source>Trends Immunol</source><year>2002</year><volume>23</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">11929132</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1471-4906(01)02149-4</pub-id></element-citation></ref><ref id="b25"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>SC</given-names></name><name name-style="western"><surname>Tan</surname><given-names>XY</given-names></name><name name-style="western"><surname>Luxenberg</surname><given-names>DP</given-names></name><name name-style="western"><surname>Karim</surname><given-names>R</given-names></name><name name-style="western"><surname>Dunussi-Joannopoulos</surname><given-names>K</given-names></name><name name-style="western"><surname>Collins</surname><given-names>M</given-names></name><name name-style="western"><surname>Fouser</surname><given-names>LA</given-names></name></person-group><article-title>Interleukin (IL)&#8722;22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><fpage>2271</fpage><lpage>2279</lpage><pub-id pub-id-type="pmid">16982811</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20061308</pub-id><pub-id pub-id-type="pmcid">PMC2118116</pub-id></element-citation></ref><ref id="b26"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tadokera</surname><given-names>R</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>KA</given-names></name><name name-style="western"><surname>Meintjes</surname><given-names>GA</given-names></name><name name-style="western"><surname>Skolimowska</surname><given-names>KH</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>K</given-names></name><name name-style="western"><surname>Seldon</surname><given-names>R</given-names></name><name name-style="western"><surname>Rangaka</surname><given-names>MX</given-names></name><name name-style="western"><surname>Maartens</surname><given-names>G</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group><article-title>Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis</article-title><source>J Infect Dis</source><year>2013</year><volume>207</volume><fpage>1148</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">23303806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jit002</pub-id><pub-id pub-id-type="pmcid">PMC3583273</pub-id></element-citation></ref><ref id="b27"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frentsch</surname><given-names>M</given-names></name><name name-style="western"><surname>Arbach</surname><given-names>O</given-names></name><name name-style="western"><surname>Kirchhoff</surname><given-names>D</given-names></name><name name-style="western"><surname>Moewes</surname><given-names>B</given-names></name><name name-style="western"><surname>Worm</surname><given-names>M</given-names></name><name name-style="western"><surname>Rothe</surname><given-names>M</given-names></name><name name-style="western"><surname>Scheffold</surname><given-names>A</given-names></name><name name-style="western"><surname>Thiel</surname><given-names>A</given-names></name></person-group><article-title>Direct access to CD4+ T cells specific for defined antigens according to CD154 expression</article-title><source>Nat Med</source><year>2005</year><volume>11</volume><fpage>1118</fpage><lpage>1124</lpage><pub-id pub-id-type="pmid">16186818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nm1292</pub-id></element-citation></ref><ref id="b28"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klug-Micu</surname><given-names>GM</given-names></name><name name-style="western"><surname>Stenger</surname><given-names>S</given-names></name><name name-style="western"><surname>Sommer</surname><given-names>A</given-names></name><name name-style="western"><surname>Liu</surname><given-names>PT</given-names></name><name name-style="western"><surname>Krutzik</surname><given-names>SR</given-names></name><name name-style="western"><surname>Modlin</surname><given-names>RL</given-names></name><name name-style="western"><surname>Fabri</surname><given-names>M</given-names></name></person-group><article-title>CD40 ligand and interferon-gamma induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes</article-title><source>Immunology</source><year>2013</year><volume>139</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">23289765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/imm.12062</pub-id><pub-id pub-id-type="pmcid">PMC3634544</pub-id></element-citation></ref><ref id="b29"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noelle</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Roy</surname><given-names>M</given-names></name><name name-style="western"><surname>Shepherd</surname><given-names>DM</given-names></name><name name-style="western"><surname>Stamenkovic</surname><given-names>I</given-names></name><name name-style="western"><surname>Ledbetter</surname><given-names>JA</given-names></name><name name-style="western"><surname>Aruffo</surname><given-names>A</given-names></name></person-group><article-title>A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><fpage>6550</fpage><lpage>6554</lpage><pub-id pub-id-type="pmid">1378631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.89.14.6550</pub-id><pub-id pub-id-type="pmcid">PMC49539</pub-id></element-citation></ref><ref id="b30"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahnke</surname><given-names>YD</given-names></name><name name-style="western"><surname>Roederer</surname><given-names>M</given-names></name></person-group><article-title>OMIP-001: Quality and phenotype of Ag-responsive human T-cells</article-title><source>Cytometry Part A</source><year>2010</year><volume>77A</volume><fpage>819</fpage><lpage>820</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.20944</pub-id><pub-id pub-id-type="pmid">20722005</pub-id></element-citation></ref><ref id="b31"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuleger</surname><given-names>CL</given-names></name><name name-style="western"><surname>Albertini</surname><given-names>MR</given-names></name></person-group><article-title>OMIP-008: Measurement of Th1 and Th2 cytokine polyfunctionality of human T cells</article-title><source>Cytometry Part A</source><year>2012</year><volume>81A</volume><fpage>450</fpage><lpage>452</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22035</pub-id><pub-id pub-id-type="pmcid">PMC3418807</pub-id><pub-id pub-id-type="pmid">22431369</pub-id></element-citation></ref><ref id="b32"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamoreaux</surname><given-names>L</given-names></name><name name-style="western"><surname>Koup</surname><given-names>RA</given-names></name><name name-style="western"><surname>Roederer</surname><given-names>M</given-names></name></person-group><article-title>OMIP-009: Characterization of antigen-specific human T-cells</article-title><source>Cytometry Part A</source><year>2012</year><volume>81A</volume><fpage>362</fpage><lpage>363</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22042</pub-id><pub-id pub-id-type="pmid">22438322</pub-id></element-citation></ref></ref-list><sec sec-type="supplementary-material"><title>Supporting Information</title><p>Additional Supporting Information may be found in the online version of this article.</p><supplementary-material content-type="local-data" id="sd1" position="float" orientation="portrait"><caption><p>Supplementary Information</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="docx" mime-subtype="docx" xlink:href="cyto0085-0576-sd1.docx" id="d35e1926" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd2" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 1.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="tif" mime-subtype="tif" xlink:href="cyto0085-0576-sd2.tif" id="d35e1931" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd3" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 3.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd3.ps" id="d35e1936" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd4" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 3.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd4.ps" id="d35e1941" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd5" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 4.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd5.ps" id="d35e1946" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd6" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 5.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd6.ps" id="d35e1951" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd7" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 6.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd7.ps" id="d35e1956" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd8" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 7.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd8.ps" id="d35e1961" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd9" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 8.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd9.ps" id="d35e1966" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="sd10" position="float" orientation="portrait"><caption><p>Supplementary Information Figure 9.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" mimetype="ps" mime-subtype="ps" xlink:href="cyto0085-0576-sd10.ps" id="d35e1972" position="anchor" orientation="portrait"/></supplementary-material></sec></back></article></pmc-articleset>